SLE | Docwire News

SLE

Risk Factors for SLE Development in Patients With ITP

Patrick DalyITP | August 28, 2023

Researchers, led by Soo Min Ahn, examined patients with primary immune thrombocytopenia (ITP) who later developed ...

Risk Factors for Progression of Immune Thrombocytopenia to Systemic Lupus Erythematosus

Patrick DalyITP | August 28, 2023

Researchers, led by Yuqing Song, sought to uncover potential risk factors driving progression of immune thrombocytopenia ...

The Great Debate: Belimumab or Voclosporin for Lupus Nephritis?

Mithu Maheswaranathan, MDRheumatology | October 11, 2023

The debate discussed benefits and drawbacks of these two agents. See why Dr. Michelle Petri argues in favor of belimumab.

Patients with Rheumatic Disease Are Protecting Themselves from COVID-19—But At What Cost?

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

Patients with chronic rheumatic diseases (CRD) had much lower seroprevalence of SARS-CoV-2 antibodies compared to blood ...

Rheum Round-up: Tocilizumab and Diverticulitis Risk, Pulmonary Arterial Hypertension With Connective Tissue Disease, and more

Kaitlyn D’OnofrioRheumatology | May 21, 2021

Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to ...

Predicting Preterm Birth in Pregnancies of Women with Systemic Lupus Erythematosus

Kaitlyn D’OnofrioRheumatology | April 12, 2023

A study identified factors predictive of preterm birth in pregnant women with systemic lupus erythematosus (SLE), ...

Hydroxychloroquine Improves Vascular Outcomes in Patients with Systemic Lupus Erythematosus

Kaitlyn D’OnofrioThrombosis | September 6, 2023

Patients with systemic lupus erythematosus (SLE) taking hydroxychloroquine may also benefit from improved vascular ...

Are Lung Cancer Treatment and Survival Different for Patients With Autoimmune Diseases?

Kaitlyn D’OnofrioLung Cancer | October 27, 2023

Patients with autoimmune diseases—including rheumatoid arthritis (RA)—do not have poorer lung cancer survival ...

Rheum Round-up: Hydroxychloroquine Exposure and COVID-19 Risk, and Much More

Kaitlyn D’OnofrioRheumatology | December 18, 2020

Can Pre-exposure to Hydroxychloroquine Prevent COVID-19 in Patients with RA and SLE? ...

Can Pre-exposure to Hydroxychloroquine Prevent COVID-19 in Patients with RA and SLE?

Kaitlyn D’OnofrioCOVID-19 | April 7, 2023

At the onset of the COVID-19 pandemic, hydroxychloroquine became a hot topic as a possible treatment for the virus. ...

Rheum Round-up: Interview With Richard Furie, MD; Orthopedics’ Diversity Problem, and Much More

Kaitlyn D’OnofrioRheumatology | November 20, 2020

Interview: Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE ...

Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE

Kaitlyn D’OnofrioACR 2020 Conference | August 1, 2023

During the American College of Rheumatology (ACR) Convergence 2020, several presentations discussed data on the use of ...

Healthcare Visits, DMARD Treatment Both Interrupted for Autoimmune Rheumatic Patients During COVID-19

Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023

The COVID-19 pandemic impacted virtually all areas of health care, whether it be access to medication, conversions to ...

The Latest Research on Baricitinib, Eli Lilly’s Arthritis Drug Used to Treat COVID-19

Kaitlyn D’OnofrioRheumatoid Arthritis | April 7, 2023

Eli Lilly’s rheumatoid arthritis (RA) drug baricitinib, marketed as Olumiant, has been the subject of several clinical ...

Rheum Round-up: FDA Rejects RA Drug, SLE Racial Disparities, and more

Kaitlyn D’OnofrioRheumatology | August 21, 2020

Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about why ...

SLE Patients May Be Able to Safely Discontinue Hydroxychloroquine Without Increasing Flares

Kaitlyn D’OnofrioRheumatology | August 21, 2020

Many systemic lupus erythematosus (SLE) patients take hydroxychloroquine to help manage their disease. Benefits of the ...

Rheum Round-up: Hydroxychloroquine Still A Flop for COVID-19, Real-World RA Treatment Comparison, and more

Kaitlyn D’OnofrioRheumatology | May 15, 2020

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about more ...

Rheum Round-up: Interivew with a Rheumatologist, Hydroxychloroquine and COVID-19 Prevention, and more

Kaitlyn D’OnofrioRheumatology | September 12, 2023

Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an ...

What You Need to Know About Hydroxychloroquine and COVID-19 Prevention

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

Rumors that lupus patients are protected from COVID-19 because many of them take hydroxychloroquine are just ...

Organizations Call on Pharmacy Boards to Make Sure Patients Receive Chloroquine and Hydroxychloroquine, A ‘Life-Saving’ Lupus Therapy, Amid COVID-19 Experimental Use

Kaitlyn D’OnofrioCOVID-19 | April 6, 2023

Nationwide shortages of hydroxychloroquine (Plaquenil) and chloroquine (Aralen) have raised concern among patients who ...